BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 19379066)

  • 1. Management of hypertension in chronic heart failure.
    Manickavasagam S; Merla R; Koerner MM; Fujise K; Kunapuli S; Rosanio S; Barbagelata A
    Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):423-33. PubMed ID: 19379066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure with preserved left ventricular systolic function among patients with non-ST-segment elevation acute coronary syndromes.
    Bennett KM; Hernandez AF; Chen AY; Mulgund J; Newby LK; Rumsfeld JS; Hochman JS; Hoekstra JW; Ohman EM; Gibler WB; Roe MT; Peterson ED
    Am J Cardiol; 2007 May; 99(10):1351-6. PubMed ID: 17493458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACC/AHA guideline update: treatment of heart failure with reduced left ventricular ejection fraction.
    Aronow WS
    Geriatrics; 2006 Mar; 61(3):22-9. PubMed ID: 16522132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of diastolic dysfunction in hypertension.
    Ginelli P; Bella JN
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):613-8. PubMed ID: 22743209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure and its treatment in women. Role of hypertension, diabetes, and estrogen.
    Regitz-Zagrosek V; Lehmkuhl E
    Herz; 2005 Aug; 30(5):356-67. PubMed ID: 16132238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure update: treatment of heart failure with a normal left ventricular ejection fraction in the elderly.
    Aronow WS
    Geriatrics; 2006 Aug; 61(8):16-20. PubMed ID: 16901193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockers.
    Hilleman DE
    Pharmacotherapy; 1993; 13(5 Pt 2):88S-93S. PubMed ID: 7901842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure in elderly patients.
    Aronow WS
    Heart Dis; 2003; 5(4):279-94. PubMed ID: 12877761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic heart failure: an overview of conventional treatment versus novel approaches.
    Landmesser U; Drexler H
    Nat Clin Pract Cardiovasc Med; 2005 Dec; 2(12):628-38. PubMed ID: 16306919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a review. III. Angiotensin-converting enzyme inhibitors.
    Ascenção R; Fortuna P; Reis I; Carneiro AV
    Rev Port Cardiol; 2008 Sep; 27(9):1169-87. PubMed ID: 19044179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents.
    Prisant LM
    Am J Med; 2008 Aug; 121(8 Suppl):S8-15. PubMed ID: 18638617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term trends in drug prescription for hospitalized patients with congestive heart failure. Influence of type of dysfunction].
    Grigorian Shamagian L; Varela Román A; Virgos Lamela A; Rigueiro Veloso P; García Acuña JM; González-Juanatey JR
    Rev Esp Cardiol; 2005 Apr; 58(4):381-8. PubMed ID: 15847735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure.
    Aronow WS
    Cardiol Rev; 2006; 14(3):108-24. PubMed ID: 16628020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of congestive heart failure in the elderly patient.
    Aronow WS
    Compr Ther; 1995 Jul; 21(7):329-38. PubMed ID: 7554808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of diastolic heart failure.
    Kazik A; Wilczek K; Poloński L
    Cardiol J; 2010; 17(6):558-65. PubMed ID: 21154257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of heart failure with abnormal left ventricular systolic function in the elderly.
    Aronow WS
    Clin Geriatr Med; 2007 Feb; 23(1):61-81. PubMed ID: 17126755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers for primary prevention of heart failure in patients with hypertension insights from a meta-analysis.
    Bangalore S; Wild D; Parkar S; Kukin M; Messerli FH
    J Am Coll Cardiol; 2008 Sep; 52(13):1062-72. PubMed ID: 18848139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.